Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers
Clinical trial NCT03495609 · COMPLETED
Trial details
- NCT number
- NCT03495609
- Sponsor
- University Hospital, Ghent
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-17
- Primary completion
- 2018-12-18
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.